Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
Lewnard et al., The Lancet Infectious Diseases, doi:10.1016/S1473-3099(23)00118-4
https://c19early.org/lewnard.html